Using AI to predict and design vaccines and antibodies against COVID-19 variants
AI-based platform for predicting emerging vaccine-escape variants and designing mutation-proof antibodies
['FUNDING_R01'] · MICHIGAN STATE UNIVERSITY · NIH-11080364
This study is looking at how COVID-19 variants change over time and how those changes might affect vaccines, with the goal of creating better treatments and vaccines for everyone.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MICHIGAN STATE UNIVERSITY (nih funded) |
| Locations | 1 site (EAST LANSING, UNITED STATES) |
| Trial ID | NIH-11080364 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding and predicting how COVID-19 variants, particularly those that can evade vaccines, will evolve. By combining genomic analysis with advanced artificial intelligence and computational methods, the team aims to forecast which mutations will occur in the virus and how these changes might affect vaccine effectiveness. The project also seeks to design new antibodies that can withstand these mutations, potentially leading to more effective treatments for COVID-19. Patients may benefit from improved vaccines and therapies that are better equipped to handle emerging variants.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of COVID-19 infection, particularly those who may be affected by vaccine-escape variants.
Not a fit: Patients who are not at risk for COVID-19 or who have already been effectively vaccinated against all known variants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines and antibody treatments that can combat emerging COVID-19 variants.
How similar studies have performed: Other research has shown promise in using AI and genomic analysis to predict viral mutations, indicating that this approach has potential for success.
Where this research is happening
EAST LANSING, UNITED STATES
- MICHIGAN STATE UNIVERSITY — EAST LANSING, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WEI, GUOWEI — MICHIGAN STATE UNIVERSITY
- Study coordinator: WEI, GUOWEI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.